FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.2  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Trazodone 150mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Trazodone 100mg capsules (Bristol Laboratories Ltd) 56 capsule 4 x 14 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Trazodone 100mg capsules (Bristol Laboratories Ltd) 56 capsule 4 x 14 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 10mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Rabeprazole 20mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 4 x 7 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 4mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Montelukast 5mg chewable tablets sugar free (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Bristol Laboratories Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Anagrelide 500microgram capsules (Sandoz Ltd) 100 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Anagrelide 500microgram capsules (Sandoz Ltd) 100 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) Has concentration strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 20mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 20mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 100mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoprolol 100mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ceftazidime 2g powder for solution for injection vials (Fresenius Kabi Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 4g / Tazobactam 500mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Amitriptyline 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amitriptyline 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amitriptyline 25mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amitriptyline 25mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amitriptyline 50mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amitriptyline 50mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sertraline 100mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sertraline 100mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sertraline 50mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sertraline 50mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Colchicine 500microgram tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Colchicine 500microgram tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nefopam 30mg tablets (Ria Generics Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nefopam 30mg tablets (Ria Generics Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Amantadine 100mg capsules (Accord Healthcare Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Amantadine 100mg capsules (Accord Healthcare Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Fenofibrate micronised 267mg capsules (Accord Healthcare Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Fenofibrate micronised 267mg capsules (Accord Healthcare Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Co-amoxiclav 500mg/100mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Co-amoxiclav 1000mg/200mg powder for solution for injection vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Anagrelide 500microgram capsules (AOP Orphan Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Anagrelide 500microgram capsules (AOP Orphan Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Colchicine 500microgram tablets 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Colchicine 500microgram tablets 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Colchicine 500microgram tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Colchicine 500microgram tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 25mg tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 25mg tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Nortriptyline 10mg tablets 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Nortriptyline 10mg tablets 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Fluoxetine 60mg capsules 60 capsule Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Fluoxetine 60mg capsules 60 capsule Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) 100 ml Has concentration strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Liqua-E 500mg/5ml oral suspension (TriOn Pharma Ltd) 100 ml Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) 120 capsule 12 x 10 capsules Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Carbocisteine 375mg capsules (Glenmark Pharmaceuticals Europe Ltd) 120 capsule 12 x 10 capsules Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Entecavir 500microgram tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Enalapril 20mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Enalapril 20mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Metoprolol 50mg tablets (Bristol Laboratories Ltd) 56 tablet 4 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1

    Start Previous Page 326 of 342 Next End

    This concept is not in any reference sets

    Back to Start